Journal
ACS APPLIED NANO MATERIALS
Volume 6, Issue 7, Pages 5384-5393Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsanm.2c05512
Keywords
Alzheimer?s disease; photothermal therapy; ROS scavenger; nanozymes; microglia
Ask authors/readers for more resources
The important causes of microglial dysfunction in Alzheimer's disease (AD) include accumulation of amyloid beta (Aβ) fibrils, elevated reactive oxygen species (ROS), and hypoxia. Photothermal therapy (PTT) using a polydopamine-ruthenium nanosystem (PDA-Ru) is shown to effectively decrease Aβ deposition and restore the neuroregulatory function of microglia in AD mice. This versatile nanomaterial could serve as a potential strategy for the treatment of AD and other neurodegenerative diseases.
The important causes of microglial dysfunction include continuous accumulation of amyloid beta (Afi) fibrils, elevated reactive oxygen species (ROS), and hypoxia. They may be the key pathogenic mechanism of Alzheimer's disease (AD). Photothermal therapy (PTT) is considered an innovative and noninvasive alternative therapy due to its huge potential, which modulated the decomposition of mature Afi fibrils. Here, we report a polydopamine-ruthenium nanosystem (PDA-Ru) that is simultaneously used as the near-infrared PTT reagent, ROS scavenger, and hydrogen peroxide catalyst. The photothermal conversion performance and catalase activity of PDA were improved by anchoring Ru nanoparticles of small size. In vivo studies demonstrate that PDA-Ru + NIR decreases Afi deposition successfully, thereby restoring the neuroregulatory function of microglia. Ultimately, it ameliorates neuroinflammation and memory deficits in AD mice. In conclusion, the work illustrates that versatile nanomaterial can rescue neuronal damage and modulate microglia. It could serve as a potential strategy for AD treatment and other neurodegenerative diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available